CSPG4 Shows Promise for Glioblastoma CAR T Therapy.
CAR T cells directed against CSPG4 limit the growth of brain tumors in cultured neurospheres and glioma xenograft mouse models, with no signs of immune escape owing to loss of antigen expression.